Zobrazeno 1 - 10
of 30
pro vyhledávání: '"E. Laennec"'
Autor:
A.-S. Blanchet, F. Thivolet, E. Roux, G. Perrin, M. Vincent, C. Chemarin, E. Laennec, G. Frecon, S. Vuillermoz-Blas
Publikováno v:
Revue de Pneumologie Clinique. 67:298-303
Resume Nous rapportons une etude portant sur une serie retrospective monocentrique de 73 cancers du poumon operes entre juillet 2004 et decembre 2009. Tous les patients ont eu une analyse mineralogique d’un prelevement de tissu pulmonaire en plus d
Autor:
M, Vincent, G, Perrin, S, Vuillermoz-Blas, E, Laennec, A-S, Blanchet, G, Frecon, F, Thivolet, E, Roux, C, Chemarin
Publikováno v:
Revue de pneumologie clinique. 67(5)
We report on a study concerning a retrospective monocentric series of 73 lung cancers operated on between July 2004 and December 2009. All patients had a mineralogical analysis of a sample of lung tissue combined with an occupational questionnaire. T
Autor:
Elizabeth Roux, E. Laennec, Anne-Sophie Blanchet, Jean François Alex, Françoise Thivolet, Chemarin Cécile, Sylvie Vuillermoz-Blas, Michel Vincent, Gerard Frecon
Publikováno v:
Bulletin du Cancer. 97:S48-S49
Autor:
E. Laennec, G. Frecon, G. Perrin, C Chemarin, A.-S. Blanchet, J. F. Alex, E. Roux, Michel Vincent, S. Vuillermoz-Blas, F. Thivolet
Publikováno v:
European Journal of Cancer Supplements. 7:520-521
Publikováno v:
Revue des maladies respiratoires. 15(5)
Publikováno v:
Revue des maladies respiratoires. 12(5)
We report a case of acute fatal fibrosing silico-proteinosis occurring in nine months in a young woman who had voluntarily inhaled scouring powder. We recall the reports in the literature of the subacute or chronic forms associated with systemic dise
Autor:
V, Trillet-Lenoir, F, Mornex, F, Chauvin, P, Fournel, A, Voloch, M, Perol, E, Laennec, D, Piperno, J, Boyer, J M, Ardiet
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 10(1-2)
In order to evaluate the effect on prolonging survival of alternating chemotherapy and radiotherapy schedules in patients with limited disease small cell lung cancer, 89 patients were included in a multi-institutional pilot study between January 1986
Autor:
P J, Souquet, P, Fournel, M, Jorda, E, Laennec, D, Piperno, V, Trillet, P, Rebattu, J P, Bernard
Publikováno v:
Bulletin du cancer. 80(1)
From July 1987 to July 1988, 35 patients with non small cell lung cancer, stage IV, were included in a phase II trial (GLOT NPC 87/01). The treatment was as follows: cisplatin 50 mg/m2 day 1, vindesin 3 mg/m2 day 1, mitomycin 6 mg/m2 day 2, and bleom
Autor:
F, Chauvin, P J, Souquet, V, Trillet-Lenoir, I, Court-Fortune, M, Perol, D, Ecochard, P, Rebattu, E, Laennec, J P, Bernard
Publikováno v:
Revue des maladies respiratoires. 10(5)
Alternatively to the usual evaluation summary, a characteristic of small cell lung cancer, is the probability of significant diffuse metastases; the prognosis is directly linked to the extent of these metastases. Moreover, the assessment of the initi
Autor:
E. Laennec, P. Poirie, M. Vincent, B. Girodet, Jean-Michel Ardiet, L. Van-Straaten, A. Boisson, F. Levi, B. Guibert
Publikováno v:
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy ISBN: 9782817807843
Non-small-cell lung cancer (NSCLC) is the most common malignancy diagnosed both in the European Community and the United States. It is also the leading cause of cancer-related deaths in men. According to the new system UICC, stages IIIB and IV are ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75eef1b0eab6a0eda2cc06d62bb136d8
https://doi.org/10.1007/978-2-8178-0782-9_96
https://doi.org/10.1007/978-2-8178-0782-9_96